Annual D&A
$2.74 M
+$414.00 K+17.79%
December 31, 2022
Summary
- As of February 10, 2025, ORTX annual depreciation & amortization is $2.74 million, with the most recent change of +$414.00 thousand (+17.79%) on December 31, 2022.
- During the last 3 years, ORTX annual D&A has risen by +$1.07 million (+63.64%).
Performance
ORTX Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
Quarterly D&A
$652.00 K
-$3000.00-0.46%
September 30, 2023
Summary
- As of February 10, 2025, ORTX quarterly depreciation & amortization is $652.00 thousand, with the most recent change of -$3000.00 (-0.46%) on September 30, 2023.
- Over the past year, ORTX quarterly D&A has dropped by -$2000.00 (-0.31%).
Performance
ORTX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
TTM D&A
$2.67 M
-$2000.00-0.07%
September 30, 2023
Summary
- As of February 10, 2025, ORTX TTM depreciation & amortization is $2.67 million, with the most recent change of -$2000.00 (-0.07%) on September 30, 2023.
- Over the past year, ORTX TTM D&A has dropped by -$25.00 thousand (-0.93%).
Performance
ORTX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
ORTX Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +17.8% | -0.3% | -0.9% |
| 3 y3 years | +63.6% | +36.7% | +32.2% |
| 5 y5 years | +807.6% | +76.2% | +59.5% |
ORTX Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | -15.1% | -9.6% | -1.4% | -2.6% | -12.9% |
| 5 y | 5-year | at high | -38.9% | -9.6% | -31.6% | -2.6% | -37.3% |
| alltime | all time | at high | -99.8% | -9.6% | -80.7% | -2.6% | -95.3% |
Orchard Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | $652.00 K(-0.5%) | $2.67 M(-0.1%) |
| Jun 2023 | - | $655.00 K(+1.9%) | $2.67 M(-0.1%) |
| Mar 2023 | - | $643.00 K(-10.8%) | $2.67 M(-2.4%) |
| Dec 2022 | $2.74 M(+17.8%) | $721.00 K(+10.2%) | $2.74 M(+1.7%) |
| Sep 2022 | - | $654.00 K(-0.5%) | $2.70 M(+0.2%) |
| Jun 2022 | - | $657.00 K(-7.3%) | $2.69 M(+5.9%) |
| Mar 2022 | - | $709.00 K(+4.9%) | $2.54 M(+9.2%) |
| Dec 2021 | $2.33 M(+16.1%) | $676.00 K(+4.3%) | $2.33 M(+11.0%) |
| Sep 2021 | - | $648.00 K(+27.6%) | $2.10 M(+8.9%) |
| Jun 2021 | - | $508.00 K(+2.6%) | $1.93 M(-4.5%) |
| Mar 2021 | - | $495.00 K(+11.0%) | $2.02 M(+0.6%) |
| Dec 2020 | $2.00 M | $446.00 K(-6.5%) | $2.00 M(-0.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | $477.00 K(-20.4%) | $2.02 M(+2.0%) |
| Jun 2020 | - | $599.00 K(+24.3%) | $1.98 M(+10.6%) |
| Mar 2020 | - | $482.00 K(+4.3%) | $1.79 M(+6.9%) |
| Dec 2019 | $1.68 M(+39.7%) | $462.00 K(+5.5%) | $1.68 M(+8.9%) |
| Sep 2019 | - | $438.00 K(+7.1%) | $1.54 M(+4.6%) |
| Jun 2019 | - | $409.00 K(+11.7%) | $1.47 M(+2.2%) |
| Mar 2019 | - | $366.00 K(+12.6%) | $1.44 M(+20.0%) |
| Dec 2018 | $1.20 M(+297.0%) | $325.00 K(-12.2%) | $1.20 M(+37.2%) |
| Sep 2018 | - | $370.00 K(-2.1%) | $874.00 K(+73.4%) |
| Jun 2018 | - | $378.00 K(+200.0%) | $504.00 K(+300.0%) |
| Mar 2018 | - | $126.00 K | $126.00 K |
| Dec 2017 | $302.00 K(+4933.3%) | - | - |
| Dec 2016 | $6000.00 | - | - |
FAQ
- What is Orchard Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Orchard Therapeutics?
- What is Orchard Therapeutics annual D&A year-on-year change?
- What is Orchard Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Orchard Therapeutics?
- What is Orchard Therapeutics quarterly D&A year-on-year change?
- What is Orchard Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Orchard Therapeutics?
- What is Orchard Therapeutics TTM D&A year-on-year change?
What is Orchard Therapeutics annual depreciation & amortization?
The current annual D&A of ORTX is $2.74 M
What is the all time high annual D&A for Orchard Therapeutics?
Orchard Therapeutics all-time high annual depreciation & amortization is $2.74 M
What is Orchard Therapeutics annual D&A year-on-year change?
Over the past year, ORTX annual depreciation & amortization has changed by +$414.00 K (+17.79%)
What is Orchard Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of ORTX is $652.00 K
What is the all time high quarterly D&A for Orchard Therapeutics?
Orchard Therapeutics all-time high quarterly depreciation & amortization is $721.00 K
What is Orchard Therapeutics quarterly D&A year-on-year change?
Over the past year, ORTX quarterly depreciation & amortization has changed by -$2000.00 (-0.31%)
What is Orchard Therapeutics TTM depreciation & amortization?
The current TTM D&A of ORTX is $2.67 M
What is the all time high TTM D&A for Orchard Therapeutics?
Orchard Therapeutics all-time high TTM depreciation & amortization is $2.74 M
What is Orchard Therapeutics TTM D&A year-on-year change?
Over the past year, ORTX TTM depreciation & amortization has changed by -$25.00 K (-0.93%)